NL300715I1 - - Google Patents
Info
- Publication number
- NL300715I1 NL300715I1 NL300715C NL300715C NL300715I1 NL 300715 I1 NL300715 I1 NL 300715I1 NL 300715 C NL300715 C NL 300715C NL 300715 C NL300715 C NL 300715C NL 300715 I1 NL300715 I1 NL 300715I1
- Authority
- NL
- Netherlands
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Obesity (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/874,532 US7854943B2 (en) | 2004-06-24 | 2004-06-24 | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
| US11/019,218 US7858115B2 (en) | 2004-06-24 | 2004-12-23 | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
| PCT/US2005/022072 WO2006012145A1 (en) | 2004-06-24 | 2005-06-23 | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL300715I2 NL300715I2 (enExample) | 2015-12-29 |
| NL300715I1 true NL300715I1 (enExample) | 2015-12-29 |
Family
ID=35506058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL300715C NL300715I1 (enExample) | 2004-06-24 | 2015-01-27 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US7858115B2 (enExample) |
| EP (1) | EP1781256B1 (enExample) |
| JP (1) | JP4991530B2 (enExample) |
| AU (1) | AU2005267395B2 (enExample) |
| CA (1) | CA2571063C (enExample) |
| DK (1) | DK1781256T3 (enExample) |
| ES (1) | ES2407812T3 (enExample) |
| FR (1) | FR15C0009I2 (enExample) |
| LU (1) | LU92640I2 (enExample) |
| NL (1) | NL300715I1 (enExample) |
| PL (1) | PL1781256T3 (enExample) |
| PT (1) | PT1781256E (enExample) |
| WO (1) | WO2006012145A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050287180A1 (en) * | 2004-06-15 | 2005-12-29 | Chen Andrew X | Phospholipid compositions and methods for their preparation and use |
| US7858115B2 (en) * | 2004-06-24 | 2010-12-28 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
| US8679545B2 (en) | 2005-11-12 | 2014-03-25 | The Regents Of The University Of California | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| US8324192B2 (en) | 2005-11-12 | 2012-12-04 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| US8017159B2 (en) * | 2005-11-16 | 2011-09-13 | Idexx Laboratories, Inc. | Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same |
| WO2008021367A2 (en) | 2006-08-11 | 2008-02-21 | President And Fellows Of Harvard College | Moenomycin biosynthesis-related compositions and methods of use thereof |
| EP2194965B1 (en) * | 2007-08-31 | 2016-07-20 | Archimedes Development Limited | Non-aqueous pharmaceutical compositions |
| US8604004B2 (en) * | 2007-10-04 | 2013-12-10 | President And Fellows Of Harvard College | Moenomycin analogs, methods of synthesis, and uses thereof |
| CA2704949A1 (en) | 2007-11-13 | 2009-05-22 | Meritage Pharma, Inc. | Gastrointestinal delivery systems |
| US20090131386A1 (en) * | 2007-11-13 | 2009-05-21 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
| US20090123551A1 (en) * | 2007-11-13 | 2009-05-14 | Meritage Pharma, Inc. | Gastrointestinal delivery systems |
| US20090264392A1 (en) * | 2008-04-21 | 2009-10-22 | Meritage Pharma, Inc. | Treating eosinophilic esophagitis |
| JP5551685B2 (ja) | 2008-05-14 | 2014-07-16 | オトノミ―，インク． | 制御放出型コルチコステロイド組成物、および耳の疾患を処置する方法 |
| WO2009155931A1 (en) * | 2008-06-23 | 2009-12-30 | Danmarks Tekniske Universitet | Acetic acid and a buffer |
| US8318817B2 (en) | 2008-07-21 | 2012-11-27 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| CA2743675A1 (en) * | 2008-11-14 | 2010-05-20 | Shireen S. Baseeth | Organogel compositions and processes for producing |
| US11376230B2 (en) | 2011-04-18 | 2022-07-05 | Rigshospitalet Copenhagen University Hospital | Wound care product |
| DE102011110887A1 (de) | 2011-08-17 | 2013-02-21 | Merck Patent Gmbh | Verwendung von Pyrrolidinium-Triflaten in Schmiermitteln oder Sperrflüssigkeiten |
| WO2013152279A1 (en) | 2012-04-06 | 2013-10-10 | President And Fellows Of Harvard College | Chemoenzymatic methods for synthesizing moenomycin analogs |
| US9273084B2 (en) | 2012-04-06 | 2016-03-01 | President And Fellows Of Harvard College | Moenomycin analogs, methods of synthesis, and uses thereof |
| WO2013151697A1 (en) | 2012-04-06 | 2013-10-10 | President And Fellows Of Harvard College | Methods and compounds for identifying glycosyltransferase inhibitors |
| CN102631330B (zh) * | 2012-04-19 | 2013-05-29 | 海南美大制药有限公司 | 一种兰索拉唑囊泡型磷脂凝胶缓释固体制剂 |
| EA201690323A1 (ru) | 2013-08-27 | 2016-07-29 | Отономи, Инк. | Способы лечения заболеваний уха у детей |
| CN105251051B (zh) * | 2015-11-11 | 2018-02-02 | 暨南大学 | 一种表面兼有抗菌性和生物相容性的材料及制备与应用 |
| US11040004B2 (en) | 2016-09-16 | 2021-06-22 | Otonomy, Inc. | Otic gel formulations for treating otitis externa |
| JP7680653B2 (ja) * | 2019-10-11 | 2025-05-21 | デクラ ベテリナリー プロダクツ リミテッド ライアビリティー カンパニー | 耳用製剤、方法およびデバイス |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2909466A (en) | 1956-05-29 | 1959-10-20 | Pfizer & Co C | Stable solutions of oxytetracycline salts |
| US4025620A (en) | 1975-10-22 | 1977-05-24 | Leo Pharmaceutical Products Ltd., A/S | Treatment of canine otitis and composition therefor |
| NZ184548A (en) | 1976-07-06 | 1981-10-19 | Bayer A | Antimycotic compositions comprising imidazol-1-yl-(4-phenoxyphenyl)-(pyrid-2-yl)-phenylmethane |
| IE53610B1 (en) | 1981-12-14 | 1988-12-21 | Merck & Co Inc | Waterless thixotropic composition |
| JPS6087215A (ja) | 1983-10-19 | 1985-05-16 | Mitsui Toatsu Chem Inc | 外用薬用基材 |
| FR2570602B1 (fr) | 1984-09-21 | 1986-11-28 | Cird | Vehicule pharmaceutique pour substances actives se presentant sous forme d'un gel anhydre |
| US4678516A (en) | 1984-10-09 | 1987-07-07 | The Dow Chemical Company | Sustained release dosage form based on highly plasticized cellulose ether gels |
| US4837008A (en) | 1985-04-09 | 1989-06-06 | Peroxydent Group | Periodontal composition and method |
| US4843096A (en) | 1985-06-26 | 1989-06-27 | Stiefel Laboratories, Inc. | Treatment of acne |
| US4847267A (en) | 1986-03-17 | 1989-07-11 | Charles Of The Ritz Group Ltd. | Skin treatment composition and method |
| US5091171B2 (en) | 1986-12-23 | 1997-07-15 | Tristrata Inc | Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use |
| US4814173A (en) | 1987-09-08 | 1989-03-21 | Warner-Lambert Company | Silicone elastomer transdermal matrix system |
| US5446070A (en) | 1991-02-27 | 1995-08-29 | Nover Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
| US5110809A (en) | 1988-03-21 | 1992-05-05 | Bristol-Myers Squibb Company | Antifungal gel formulations |
| GB2256588B (en) | 1990-11-09 | 1994-08-10 | Teikoku Seiyaku Kk | Preparation for transdermal administration of procaterol |
| US6005001A (en) | 1991-05-20 | 1999-12-21 | Novartis Ag (Formerly Sandoz Ag) | Pharmaceutical composition |
| HU223343B1 (hu) | 1991-05-20 | 2004-06-28 | Novartis Ag. | Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására |
| FR2680619B1 (fr) * | 1991-08-21 | 1993-12-24 | Sgs Thomson Microelectronics Sa | Predicteur d'image. |
| DE4200821A1 (de) * | 1992-01-15 | 1993-07-22 | Bayer Ag | Geschmacksmaskierte pharmazeutische mittel |
| JP3190441B2 (ja) * | 1992-07-20 | 2001-07-23 | エーザイ株式会社 | 塩酸アゼラスチンを含有する安定な製剤 |
| ZA934893B (en) | 1992-07-20 | 1995-01-09 | Colgate Palmolive Co | Gelled organic liquids |
| SI9300468A (en) * | 1992-10-14 | 1994-06-30 | Hoffmann La Roche | Injectable composition for the sustained release of biologically active compounds |
| EP0604806A3 (de) | 1992-12-18 | 2000-07-19 | Rhone-Poulenc Rorer Gmbh | Phospholipidische Zusammensetzung |
| US5631004A (en) | 1993-09-30 | 1997-05-20 | Alcon Laboratories, Inc. | Use of sustained release antibiotic compositions in ophthalmic surgical procedures |
| IT1270999B (it) * | 1994-07-26 | 1997-05-26 | Indena Spa | Formulazioni a base di cumarine e loro uso in campo farmaceutico e cosmetico |
| US5516808A (en) | 1994-10-27 | 1996-05-14 | Sawaya; Assad S. | Topical cellulose pharmaceutical formulation |
| US5849761A (en) * | 1995-09-12 | 1998-12-15 | Regents Of The University Of California | Peripherally active anti-hyperalgesic opiates |
| US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| AU707949C (en) | 1996-07-30 | 2006-01-19 | Merial, Inc. | Anthelmintic formulations |
| PT949905E (pt) * | 1996-12-20 | 2001-12-28 | Alza Corp | Composicao de gel injectavel de efeito retardado e processo para a sua preparacao |
| JPH10194994A (ja) * | 1997-01-16 | 1998-07-28 | Pola Chem Ind Inc | 吸収促進組成物 |
| US6630168B1 (en) | 1997-02-20 | 2003-10-07 | Biomedicines, Inc. | Gel delivery vehicles for anticellular proliferative agents |
| US6018033A (en) | 1997-05-13 | 2000-01-25 | Purdue Research Foundation | Hydrophilic, hydrophobic, and thermoreversible saccharide gels and forms, and methods for producing same |
| WO1999030690A1 (en) * | 1997-12-15 | 1999-06-24 | Axia Therapeutics, Inc. | Oral delivery formulation |
| US20010003580A1 (en) | 1998-01-14 | 2001-06-14 | Poh K. Hui | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
| BE1011899A6 (fr) * | 1998-04-30 | 2000-02-01 | Ucb Sa | Compositions pharmaceutiques gelifiables utilisables. |
| US6436455B2 (en) | 1998-06-15 | 2002-08-20 | General Mills, Inc. | Multi-colored aerated confectionery products |
| US6146664A (en) | 1998-07-10 | 2000-11-14 | Shaklee Corporation | Stable topical ascorbic acid compositions |
| GB2340751B (en) | 1998-08-12 | 2003-11-05 | Edko Trading Representation | Pharmaceutical compositions |
| US6238683B1 (en) | 1998-12-04 | 2001-05-29 | Johnson & Johnson Consumer Companies, Inc. | Anhydrous topical skin preparations |
| US6080744A (en) * | 1999-02-10 | 2000-06-27 | Ayon-Covarrubias; Blas | Topical antifungal treatment |
| US6395300B1 (en) | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
| US7919119B2 (en) | 1999-05-27 | 2011-04-05 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
| ITMI991453A1 (it) * | 1999-07-01 | 2001-01-01 | Farmila Farma Milano | Composizioni oftalmiche in forma di gel acquosi |
| DE19940227A1 (de) | 1999-08-25 | 2001-03-08 | Merckle Gmbh | Phospholipidgel |
| US6214339B1 (en) | 2000-01-12 | 2001-04-10 | Michael A. Pellico | Di-enzymatic treatment of outer ear infection in dogs and cats |
| US6565873B1 (en) | 2000-10-25 | 2003-05-20 | Salvona Llc | Biodegradable bioadhesive controlled release system of nano-particles for oral care products |
| US6787568B1 (en) | 2000-11-27 | 2004-09-07 | Phoenix Scientific, Inc. | Antibiotic/analgesic formulation and a method of making this formulation |
| CN1194679C (zh) | 2001-04-28 | 2005-03-30 | 沈阳药科大学 | 曲尼斯特外用脂质凝胶剂及其制法 |
| RU2292871C2 (ru) | 2001-10-19 | 2007-02-10 | Айдекс Лэборэтериз, Инк. | Инъецируемые композиции для контролируемой доставки фармакологически активного соединения |
| US20040124753A1 (en) * | 2002-08-29 | 2004-07-01 | Stoller Harry R. | Storage unit with rolling tray arrangement for heavy loads |
| WO2004037197A2 (en) | 2002-10-24 | 2004-05-06 | Goldstein Jay A | Antifungal formulations |
| US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
| US7220431B2 (en) | 2002-11-27 | 2007-05-22 | Regents Of The University Of Minnesota | Methods and compositions for applying pharmacologic agents to the ear |
| DE60212418D1 (de) * | 2002-12-19 | 2006-07-27 | Ind Bergamasca Rifrangenti S R | Verfahren zur Herstellung eines bedruckten, retroreflektierenden Materials |
| US20040197408A1 (en) | 2002-12-30 | 2004-10-07 | Angiotech International Ag | Amino acids in micelle preparation |
| US20040220264A1 (en) | 2003-03-17 | 2004-11-04 | Yu Ruey J | Bioavailability and improved delivery of acidic pharmaceutical drugs |
| US20050009931A1 (en) | 2003-03-20 | 2005-01-13 | Britten Nancy Jean | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| US20040214753A1 (en) | 2003-03-20 | 2004-10-28 | Britten Nancy Jean | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| US20040204471A1 (en) | 2003-03-20 | 2004-10-14 | Pharmacia Corporation | Treatment and prevention of otic disorders with Cox-2 inhibitors alone or in combination with otic agents |
| CN1761487A (zh) | 2003-03-20 | 2006-04-19 | 法玛西雅公司 | 抗炎剂的可分散制剂 |
| US8003616B2 (en) | 2004-04-23 | 2011-08-23 | Albert Rory J | Composition for the treatment of ear infections and method |
| US7618651B2 (en) | 2004-06-24 | 2009-11-17 | Idexx Laboratories | Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same |
| US7854943B2 (en) * | 2004-06-24 | 2010-12-21 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
| US7858115B2 (en) * | 2004-06-24 | 2010-12-28 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
-
2004
- 2004-12-23 US US11/019,218 patent/US7858115B2/en active Active
-
2005
- 2005-06-23 PT PT57662447T patent/PT1781256E/pt unknown
- 2005-06-23 WO PCT/US2005/022072 patent/WO2006012145A1/en not_active Ceased
- 2005-06-23 US US11/159,203 patent/US7846472B2/en active Active
- 2005-06-23 DK DK05766244.7T patent/DK1781256T3/da active
- 2005-06-23 ES ES05766244T patent/ES2407812T3/es not_active Expired - Lifetime
- 2005-06-23 JP JP2007518237A patent/JP4991530B2/ja not_active Expired - Lifetime
- 2005-06-23 PL PL05766244T patent/PL1781256T3/pl unknown
- 2005-06-23 CA CA2571063A patent/CA2571063C/en not_active Expired - Lifetime
- 2005-06-23 EP EP05766244A patent/EP1781256B1/en not_active Expired - Lifetime
- 2005-06-23 AU AU2005267395A patent/AU2005267395B2/en not_active Expired
-
2010
- 2010-10-21 US US12/908,993 patent/US8361496B2/en not_active Expired - Lifetime
-
2015
- 2015-01-23 LU LU92640C patent/LU92640I2/xx unknown
- 2015-01-27 NL NL300715C patent/NL300715I1/nl unknown
- 2015-01-29 FR FR15C0009C patent/FR15C0009I2/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20050287200A1 (en) | 2005-12-29 |
| US20050287181A1 (en) | 2005-12-29 |
| US8361496B2 (en) | 2013-01-29 |
| FR15C0009I2 (fr) | 2016-01-22 |
| JP2008504271A (ja) | 2008-02-14 |
| JP4991530B2 (ja) | 2012-08-01 |
| CA2571063C (en) | 2013-03-12 |
| EP1781256A4 (en) | 2012-05-09 |
| US7846472B2 (en) | 2010-12-07 |
| US7858115B2 (en) | 2010-12-28 |
| LU92640I2 (fr) | 2015-10-27 |
| WO2006012145A1 (en) | 2006-02-02 |
| PL1781256T3 (pl) | 2013-07-31 |
| AU2005267395B2 (en) | 2010-03-25 |
| NL300715I2 (enExample) | 2015-12-29 |
| DK1781256T3 (da) | 2013-05-13 |
| EP1781256A1 (en) | 2007-05-09 |
| PT1781256E (pt) | 2013-04-01 |
| ES2407812T3 (es) | 2013-06-14 |
| EP1781256B1 (en) | 2013-02-20 |
| CA2571063A1 (en) | 2006-02-02 |
| US20110034430A1 (en) | 2011-02-10 |
| AU2005267395A1 (en) | 2006-02-02 |